Pew Urges HHS to Continue Strong Implementation, Enforcement of Drug Compounding Law
The Pew Charitable Trusts, together with the American Public Health Association, the Association for Accessible Medicines, the Biotechnology Innovation Organization, and the Pharmaceutical Research and Manufacturers of America, sent a letter to the acting secretary of the Department of Health and Human Services (HHS).
The groups applauded HHS’s significant progress toward implementing the Drug Quality and Security Act of 2013 and creating a clear framework for compounded medicines. As the administration continues to develop the new oversight system, the groups also urged the department to ensure that compounded medications are made under appropriate quality standards by upholding three principles: that a prescription is the line between outsourcing facilities and traditional compounders, that flexibility for outsourcing facilities does not compromise patient safety, and that traditional compounders produce drugs under sanitary conditions.
Spotlight on Mental Health
MORE FROM PEW
Explore Pew’s new and improved
Fiscal 50 interactive
Your state's stats are more accessible than ever with our new and improved Fiscal 50 interactive:
- Maps, trends, and customizable charts
- 50-state rankings
- Analysis of what it all means
- Shareable graphics and downloadable data
- Proven fiscal policy strategies
Welcome to the new Fiscal 50
Key changes include:
- State pages that help you keep track of trends in your home state and provide national and regional context.
- Interactive indicator pages with highly customizable and shareable data visualizations.
- A Budget Threads feature that offers Pew’s read on the latest state fiscal news.